Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

ClinicalTrials.gov ID: NCT03659916

Public ClinicalTrials.gov record NCT03659916. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of A4250 in Children With Progressive Familial Intrahepatic Cholestasis Types 1 and 2 (PEDFIC 2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Open-label extension study to evaluate long-term safety and persistence of effect of A4250 in children with progressive familial intrahepatic cholestasis (PFIC).

Study identification

NCT ID
NCT03659916
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Albireo, an Ipsen Company
Industry
Enrollment
116 participants

Conditions and interventions

Eligibility (public fields only)

Age range
0 Months to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2018 (Actual)
Primary completion
Feb 15, 2024 (Actual)
Completion
Dec 2, 2025 (Actual)
Last update posted
Oct 21, 2026

2018 – 2025

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027 —
Children's Hospital Colorado Denver Colorado 80045 —
Emory University School of Medicine Atlanta Georgia 30329 —
Riley Hospital for Children - Riley Children's Specialists Indianapolis Indiana 46202 —
Johns Hopkins School of Medicine Baltimore Maryland 21287 —
Washington University School of Medicine St Louis Missouri 63110 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Columbia University Medical Center - Presbyterian Hospital Building New York New York 10032 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
Baylor College of Medicine - Texas Children's Liver Center Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03659916, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 21, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03659916 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →